Screener
Asset Entities ASST Medical Device — Fund management and administration
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Asset Entities in its filing.
Tagged under the XBRL concept asst:FundManagementAndAdministrativeExpense.
The source filing: Asset Entities’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054985
| Line item | Successor / Three Months Ended June 30, 2026 | Predecessor / Three Months Ended June 30, 2025 |
|---|---|---|
| Other revenue | 41 | 23 |
| Total revenues | 2,941 | 1,511 |
| Operating expenses: | ||
| Fund management and administration | 1,489 | 1,588 |
| Employee compensation and benefits | 16,314 | 2,005 |
| General and administrative expense | 6,428 | 1,452 |
| Marketing and advertising | 79 | 102 |
| Depreciation and amortization | 86 | 54 |
Item 1. Consolidated Financial Statements
FAQ
- What is Asset Entities's medical device — fund management and administration?
- Asset Entities (ASST) reported medical device — fund management and administration of $0 in Q2 2026.
- What does medical device — fund management and administration mean?
- This represents the costs associated with managing, overseeing, and administering the operational or financial activities of the specific business segment. It captures the overhead required to maintain the segment's infrastructure and regulatory compliance. Monitoring these expenses is essential for evaluating the operational efficiency of the segment's management structure.
Ask your AI about Asset Entities's medical device — fund management and administration.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude